[HTML][HTML] Effect of tocilizumab vs usual care in adults hospitalized with COVID-19 and moderate or severe pneumonia: a randomized clinical trial

…, V Pourchet-Martinez, F Schlemmer… - JAMA internal …, 2021 - jamanetwork.com
Importance Severe pneumonia with hyperinflammation and elevated interleukin-6 is a common
presentation of coronavirus disease 2019 (COVID-19). Objective To determine whether …

Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β–dependent adaptive immunity against tumors

…, G Mignot, E Ullrich, JL Perfettini, F Schlemmer… - Nature medicine, 2009 - nature.com
The therapeutic efficacy of anticancer chemotherapies may depend on dendritic cells (DCs),
which present antigens from dying cancer cells to prime tumor-specific interferon-γ (IFN-γ)–…

Immunogenic death of colon cancer cells treated with oxaliplatin

A Tesniere, F Schlemmer, V Boige, O Kepp, I Martins… - Oncogene, 2010 - nature.com
Both the pre-apoptotic exposure of calreticulin (CRT) and the post-apoptotic release of high-mobility
group box 1 protein (HMGB1) are required for immunogenic cell death elicited by …

Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases

…, M Saporiti, P Scarpellini, F Schlemmer… - European …, 2020 - Eur Respiratory Soc
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease (COVID-19)
pandemic has attracted interest because of its global rapid spread, clinical severity, high …

Clinical efficacy of hydroxychloroquine in patients with covid-19 pneumonia who require oxygen: observational comparative study using routine care data

…, R Lepeule, TA Szwebel, FX Lescure, F Schlemmer… - Bmj, 2020 - bmj.com
Objective To assess the effectiveness of hydroxychloroquine in patients admitted to hospital
with coronavirus disease 2019 (covid-19) pneumonia who require oxygen. Design …

Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial

…, F Pene, V Pourchet-Martinez, F Schlemmer… - The Lancet …, 2021 - thelancet.com
Background Patients with COVID-19 pneumonia have an excess of inflammation and
increased concentrations of cytokines including interleukin-1 (IL-1). We aimed to determine …

No evidence of clinical efficacy of hydroxychloroquine in patients hospitalised for COVID-19 infection and requiring oxygen: results of a study using routinely collected …

…, R Lepeule, TA Szwebel, X Lescure, F Schlemmer… - medrxiv, 2020 - medrxiv.org
Background Treatments are urgently needed to prevent respiratory failure and deaths from
coronavirus disease 2019 (COVID-19). Hydroxychloroquine (HCQ) has received worldwide …

[PDF][PDF] Anticancer chemotherapy-induced intratumoral recruitment and differentiation of antigen-presenting cells

…, D Hannani, H Duret, K Steegh, I Martins, F Schlemmer… - Immunity, 2013 - cell.com
The therapeutic efficacy of anthracyclines relies on antitumor immune responses elicited by
dying cancer cells. How chemotherapy-induced cell death leads to efficient antigen …

[PDF][PDF] Rapid and severe Covid‐19 pneumonia with severe acute chest syndrome in a sickle cell patient successfully treated with tocilizumab

…, M Colard, ALPH d'Alexandry, F Schlemmer… - American journal of …, 2020 - academia.edu
IMAGE 1 CT scan of the chest: Acute chest syndrome and Covid-19-induced pneumonia. A,
Axial image of chest obtained with a soft-tissue windows at the level of the lower lobes …

Cardiac glycosides exert anticancer effects by inducing immunogenic cell death

…, M Michaud, G Mignot, F Schlemmer… - Science translational …, 2012 - science.org
Some successful chemotherapeutics, notably anthracyclines and oxaliplatin, induce a type
of cell stress and death that is immunogenic, hence converting the patient’s dying cancer …